期刊文献+

健脾理气法治疗原发性肝癌预后的单因素及多因素分析 被引量:13

Treating Primary Liver Cancer Patients by Pi-strengthening and Qi-regulating Method: Univariate and Multivariate Analyses of Their Prognoses
原文传递
导出
摘要 目的探讨影响健脾理气法治疗原发性肝癌的预后因素,为健脾理气法治疗肝癌提供依据,并指导健脾理气法治疗方案的优化。方法回顾性分析2007年5月—2009年3月在广东省中医院接受健脾理气法治疗的151原发性肝癌患者的临床资料,对可能影响预后的各种因素进行单因素分析,将单因素分析中可能影响预后的指标依次引入COX比例风险模型进行多因素分析。结果全组患者1年生存率为21.85%,中位生存期为6.80个月,平均生存期是8.98个月。单因素分析显示,中医证型、就诊时症状、腹水情况、肿瘤类型、病灶比例、门脉癌栓、肝内转移、AFP水平、总胆红素分级、白蛋白分级、肝功能分级及中国肝癌分期等对预后有影响(P<0.05)。多因素分析表明,中医证型、腹水情况、肿瘤类型、门脉癌栓、甲胎蛋白(AFP)水平、肝功能分级及中国肝癌分期为影响肝癌预后的独立因素(P<0.05)。结论健脾理气法治疗肝癌的预后是由多种因素决定的,其中中医证型、腹水情况、肿瘤类型、门脉癌栓、AFP水平、肝功能分级及中国肝癌分期是影响其预后的主要因素。 Objective To evaluate the prognostic factors in treating primary liver cancer (PLC) patients by Pi-strengthening and qi-regulating method (PSQRM), thus providing evidence and optimizing Pi-strengthening and qi-regulating program. Methods Clinical data of 151 PLC patients treated by PSQRM at Oncology Department, Guangdong Provincial Hospital of Traditional Chinese Medicine from May 2007 to March 2009 were retrospectively analyzed. The univariate analysis was determined to ana- lyze possible prognostic factors. Selected key factors were introduced into the COX proportional hazard model, and multivariate analysis was carried out. Results The 1-year survival rate was 21.85%, the median survival time was 6.80 months, and the mean survival time was 8.98 months. The univariate a- nalysis showed that Chinese medicine (CM) syndrome types, clinical symptoms at the initial diagnosis, ascites, tumor types, ratios of foci, portal vein tumor thrombus, intrahepatic metastasis, ^-fetoprotein (AFP) levels, total bilirubin classification, albumin classification, Child-Pugh classification, and domestic staging of liver cancer were significant prognostic factors (P 〈0.05). The statistic data of multivariate a- nalysis indicated that CM syndrome types, ascites, tumor types, portal vein tumor thrombus, AFP lev- els, Child-Pugh classification, and domestic staging of liver cancer were independent factors influencing prognosis (P 〈0.05). Conclusion The prognosis of PLC treated with PSQRM is determined by multiple factors including CM syndrome types, ascites, tumor types, portal vein tumor thrombus, AFP levels, Child-Pugh classification, and domestic staging of liver cancer.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2014年第2期162-166,共5页 Chinese Journal of Integrated Traditional and Western Medicine
基金 吴阶平医学基金会资助项目(No.320.6700.1124)
关键词 原发性肝癌 健脾理气法 预后分析 primary liver cancer Pi-strengthening and qi-regulating method prognostic analysis
  • 相关文献

参考文献16

  • 1Jemal A,Bray F,Center MM. Global cancer statistics[J].{H}CA-A Cancer Journal for Clinicians,2011,(2):69-90.
  • 2周岱翰.中医肿瘤学临床研究现状与评析[J].新中医,2006,38(6):4-6. 被引量:25
  • 3刘鲁明.肝癌中西医综合治疗[M]{H}北京:人民卫生出版社,2002139-155165179183194-195205-208254-26527930.
  • 4中华医学会.临床诊疗指南肿瘤分册[M]{H}北京:人民卫生出版社,2005322-323.
  • 5刘伟胜.肿瘤科专病中医临床诊治[M]{H}北京:人民卫生出版社,2005237-238.
  • 6中国抗癌协会.新编常见恶性肿瘤诊治规范[M]{H}北京:中国协和医科大学出版社,1999450.
  • 7汤钊猷.汤钊猷临床肝癌学[M]{H}上海:上海科技教育出版社,20012-3.
  • 8中国抗癌协会肝癌专业委员会.原发性肝癌的临床诊断与分期标准[J]{H}肝脏,2004(Suppl):67-68.
  • 9于尔辛.肝癌的健脾理气方治疗[J].中国肿瘤,2000,9(8):344-344. 被引量:36
  • 10杨小兵,龙顺钦,吴万垠,邓宏,潘宗奇,河文峰,周宇姝,廖桂雅,欧阳育树,李秋萍,黄鹂,胡学军,肖舒静,蔡姣芝.原发性肝癌中医证型分布及生存期差异研究[J].中国中西医结合杂志,2013,33(7):911-914. 被引量:34

二级参考文献47

共引文献158

同被引文献156

引证文献13

二级引证文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部